Contacting Information:
Prof. Dr. Qingchun Shen
Institute of Animal Sciences, Chinese Academy of Agricultural Sciences (CAAS),
No.2 Yuanmingyuan West Road, Haidian District,
Beijing 100193, P. R. China
E-mail: shenqingchun@caas.cn
Qingchun Shen, born in Macheng,Hubei province, PhD, Professor, Master's Supervisor.
Education：
He graduated from Huazhong Agricultural University with a bachelor degree of biotechnology in 1997, June, and awarded the master degree in Huazhong Agricultural University with the major of preventive veterinary medicine in 2000. followed by the PhD degree in Chinese Agricultural University in 2010. Currently, Prof. Shen serves as the director of Department of Veterinary Science, Institute of Animal Sciences, Chinese Academy of Agricultural Sciences.
Experience:
2000.7-2022.3, in China Institute of Veterinary Drug Control (IVDC), Prof. Shen mainly focused on the prevention & control of mycoplasmal animal disease and development of veterinary biologicals. In 2012, he was assigned to Beijing Zhonghai Biotechnology Co., Ltd., an enterprise affiliated to the Central Supervision Institute, as Deputy General Manager. In 2019, he backed to the Brucellosis National / OIE reference Laboratory of IVDC.
2022.3-Now, in Institute Animal Sciences of CAAS, Prof. Shen is engaged in basic research on mycoplasma and brucellosis, zoonosis epidemiology, prevention and control technology and bioinformatics.
Research Interests and Achievements
Prof. Shen has long been committed to prevention & control of respiratory animal disease, the pathogenic including M.hyopneumoniae , M.synoviae, PRRSV and Classic Swine Fever Virus for decades, and has acquired series of original scientific achievements. He had obtained 4 new veterinary drug certificates, 3 national / industry standards, and 8 patent certificates (4 for the first inventor) and won 3 ministerial prizes.
The main achievements are as follows:
1. As a core contributor, we solved the difficulties in vaccination of live porcine mycoplasma pneumonia vaccine, large side effects and difficult balance between immunogenicity and safety of live porcine blue ear vaccine, successfully developed two kinds of live vaccines and transferred 11 enterprises; the live classical swine fever vaccine (passage cell source) has been produced in 19 enterprises.
2. Two new methods for vaccine testing, the establishment of mycoplasma PCR test method solved the problem of poor timeliness of mycoplasma test in veterinary biological products, and the general CCU50 method for accurate counting of mycoplasma live bacteria was reported for the first time, which solved the problem of lack of accurate determination technology of mycoplasma live bacteria titer.
Research Projects
National Key R&D Program: Research on Traceability Precision Diagnosis Technology and Products for Imported Animal Diseases (2022YFD1800503), November 2022 to December 2025
Papers
1.Establishment and application of PCR detection method for mycoplasma contamination in cell and viral live vaccines, China Agricultural science, 2022,55 (7): 1458-146, corresponding author
2.Analysis of predictive ability of whole genome sequencing technology for salmonella Serotype and drug resistance, Journal of Microbiology, 2021,61 (12): 4038-4047, the second author;
3.Complete Genome Sequence of Mycoplasma bovis Strain XBY01, Isolated from Henan Province, China. Microbiology Recource Announcements, 2020,Vol 9, the first author；
Inventions
1. A "spicy stick" for oral immunization or administration to large and medium-sized animals and its production method, ZL20221 0529516. X, first inventor;
2. A strain of Mycoplasma hyopneumoniae and its application, ZL201510249939.6, first inventor;
3. A universal PCR detection method for mycoplasma and its detection kit, ZL2010576699.1, first inventor;
National/industry standards
1. Testing methods for exogenous mycoplasma in veterinary biological products, GB/T 41699-2022, ranking second;
2. Animal tuberculosis diagnosis technology, GB/T 18645-2020, ranking third;
3. The qualitative PCR method for pig pseudorabies TK -/gE -/gI - strain (SA215 strain) and its products, Ministry of Agriculture Announcement No. 1485-2010, ranking first;
Vaccine development:
1. Live vaccine against Mycoplasma suis pneumonia (RM48 strain), (2014) New Veterinary Medicine Certificate No. 14, ranking 2nd;
2. Highly pathogenic Betaarterivirus suid 1 chimeric live vaccine (PC strain), (2018) New Animal Drug Certificate No. 35, ranking 2nd;
3. Swine fever live vaccine (passage cell source), (2012) New Veterinary Medicine Certificate No.01, ranking 5th.
Awards
1.The third prize of Shennong China Agricultural Science and Technology Award, the cultivation of live vaccine strain of Mycoplasma suis pneumonia and the creation and application of nasal spray immune vaccine, in November 2017, the certificate number: KJ2017-R5-030-02 2,
2.the second prize of Dabei Agricultural Science and Technology Achievement Award, the creation and application of live vaccine of Mycoplasma suis pneumonia (RM48 strain), in November 2015, the certificate number: 2015-DBNSTA-03-0233;
3. First Prize in Chinese Agricultural Science and Technology, Research and Application of Live Cell Derived Swine Fever Vaccine and Swine Fever Prevention and Control Technology。